Bacteremia Market

Bacteremia (also bacteremia) is the presence of bacteria in the blood. Blood is normally a sterile environment, so the detection of bacteria in the blood (most commonly accomplished by blood cultures) is always abnormal. It is distinct from sepsis, which is the host response to the bacteria. Bacteremia can have several important health consequences. The immune response to the bacteria can cause sepsis and septic shock, which has a high mortality rate. Bacteria can also spread via the blood to other parts of the body (which is called hematogenous spread), causing infections away from the original site of infection, such as endocarditis or osteomyelitis. Treatment for bacteremia is with antibiotics, and prevention with antibiotic prophylaxis can be given in high-risk situations.
Bacteremia Market contains market size and forecasts of Bacteremia in Global, including the following market information:
Global Bacteremia Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Bacteremia market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Antibiotics Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Bacteremia include Merck, Ronak Daru, Pfizer, Baxter, Theravance Biopharma, Novartis, Fresenius, Mylan and Sun Pharmaceutical Industries and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Bacteremia companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bacteremia Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Bacteremia Market Segment Percentages, by Type, 2021 (%)
Antibiotics
Vasopressors
Global Bacteremia Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Bacteremia Market Segment Percentages, by Application, 2021 (%)
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Global Bacteremia Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Bacteremia Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Bacteremia revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Bacteremia revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Ronak Daru
Pfizer
Baxter
Theravance Biopharma
Novartis
Fresenius
Mylan
Sun Pharmaceutical Industries
Baxter